Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05948605 · ClinicalTrials.gov registry record · NA

EMPOWER AUD Pivotal Trial

A NA study of Alcohol Use Disorder and Alcoholism, sponsored by Theranova, L.L.C..

Completed
Registry status
NA
Development phase
35
Enrollment target
2
Study locations

NCT05948605 is a NA study of Alcohol Use Disorder and Alcoholism that has completed, run by Theranova, L.L.C.. The registered enrollment target is 35 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05948605, a NA study of Alcohol Use Disorder and Alcoholism, has completed, sponsored by Theranova, L.L.C..

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

Multi-site, double-blinded, prospective, randomized, sham-controlled study

Conditions Studied

Alcohol Use Disorder Alcoholism Alcohol Abuse

Interventions

  • DEVICE Empower Neuromodulation System

Study Locations (2)

California

  • University of California, San Francisco - San Francisco

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2023-12-01
Est. Completion 2025-08-06
Phase NA

Sponsor

Theranova, L.L.C.

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05948605

The ClinicalTrials.gov registry entry for NCT05948605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Theranova, L.L.C., which has 11 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Empower Neuromodulation System is the first listed.

NCT05948605 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT05948605 about?

NCT05948605 is a clinical study titled "EMPOWER AUD Pivotal Trial". Multi-site, double-blinded, prospective, randomized, sham-controlled study

What is the current status of trial NCT05948605?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2023-12-01. Estimated completion is 2025-08-06.

What conditions does trial NCT05948605 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcoholism, Alcohol Abuse.

What interventions are being tested in trial NCT05948605?

The interventions under investigation include: Empower Neuromodulation System (DEVICE).

Who is sponsoring clinical trial NCT05948605?

This trial is sponsored by Theranova, L.L.C., which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05948605 being conducted?

This trial has 2 study locations across California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Alcoholism

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.